全球骨关节炎治疗市场 – 行业趋势及 2029 年预测

市场分析和规模

近年来，骨关节炎治疗市场预计将在预测期内快速增长。根据世界卫生组织的数据，60 岁以上的人群中约有 10% 至 15% 患有骨关节炎，女性的发病率高于男性。根据联合国的数据，到 2050 年，60 岁以上的成年人将占全球人口的 20% 以上。保守估计，这 20% 中 15% 将患有症状性骨关节炎，其中三分之一的人群病情严重。

Data Bridge Market Research 分析称，2021 年骨关节炎治疗市场价值为 62.1406 亿美元，预计到 2029 年将达到 101.003 亿美元，在 2022 年至 2029 年的预测期内复合年增长率为 6.26%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分

市场定义

影响关节的最常见慢性疾病是骨关节炎，通常称为退行性关节炎。受此影响的身体部位会因此出现急性关节疼痛和僵硬。骨关节炎可以用多种方法治疗，包括运动缓解关节疼痛和服用止痛药。非处方 (OTC) 止痛药，如对乙酰氨基酚 (泰诺) 或非甾体抗炎药 (NSAID) 可缓解骨关节炎症状。度洛西汀 (Cymbalta) 是一种处方止痛药，也可用于治疗长期 (慢性) 骨关节炎不适。类固醇注射通常可以在短期至中期内显著缓解骨关节炎疼痛。

骨关节炎治疗市场动态

驱动程序

• 骨关节炎患病率不断上升

据估计，骨关节炎患病率的上升将促进骨关节炎治疗市场的增长。受伤、肥胖和各种其他因素都会导致骨关节炎。受损的身体部位会出现严重的关节疼痛和僵硬。关节肿胀、腿部和四肢刺痛以及活动范围减少都是骨关节炎的症状。根据 2020 年 11 月发表在《柳叶刀》杂志上的一项研究，2019 年骨关节炎影响了全球约 7% 的人口，即超过 5 亿人，其中女性受影响尤为严重。从 1990 年到 2019 年，全球受骨关节炎影响的人数增加了 48%，2019 年骨关节炎是导致残疾寿命 (YLD) 的第 15 大原因。

• 增加医疗基础设施投资

Another significant factor influencing the growth rate of osteoarthritis treatment market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

• Growing number of geriatric population

The surging geriatric population is estimated to enhance the market's expansion during the forecast period of 2022-2029. According to the World Health Organization (WHO), the worldwide geriatric population, which was estimated to be over 524 million in 2010, is expected to increase to nearly 2 billion by 2050. Due to their compromised immune systems, geriatrics are more susceptible to getting osteoarthritis treatment, further estimated to enhance theirmarket's growth rate.

• Surging cases of joint injuries

The increasing number of joint injuries is estimated to elevate the 'market's growth rate. Osteoarthritis can be worsened by injuries sustained while participating in sports or as a result of an accident. Osteoarthritis can be triggered by injuries that occurred many years ago but appear to have healed.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the osteoarthritis treatment market. Additionally, rising incidences of orthopedic disorders and sedentary lifestyle of people will expand the osteoarthritis treatment market.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities of medication for symptomatic treatment of osteoarthritis. This will provide beneficial opportunities for the osteoarthritis treatment market growth. For illustration, Flexion Therapeutics, Inc. began a Phase III investigation of FX006 32 mg, which is indicated for knee osteoarthritis, in April 2018.

Moreover, rising investment in the development of advanced technologies and an increase in the number of emerging markets will provide beneficial opportunities for the osteoarthritis treatment market growth during the forecast period.

Restraints/Challenges

• Side effects linked with Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

NSAIDs, both over-the-counter and prescribed, are commonly used to treat osteoarthritis pain. According to a report published by the National Center for Biotechnology Information in 2019, NSAIDs are administered to more than half of all osteoarthritis patients in the United States. Similarly, 60 percent of osteoarthritis patients in Europe who used prescription drugs (47 percent) received NSAIDs. Nonsteroidal anti-inflammatory drugs (NSAIDs) have been linked to an enhanced risk of cardiovascular events. Both selective and non-selective NSAIDs (coxibs) increase the risk of cardiovascular disease in patients. These factors will impede the 'market's growth rate during the forecast period of 2021-2029.

On the other hand, high cost high cost associated with the treatment will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the osteoarthritis treatment market. Additionally, strict regulatory policies and lack of awareness among people will restrain and further impede the growth rate of the market during the forecast period of 2022-2029.

This osteoarthritis treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the osteoarthritis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

X-rays reveal osteoarthritis in about 80% of elderly persons aged 55 and more. Approximately 60% of these people suffer from symptoms. Symptomatic osteoarthritis affects an estimated 240 million adults globally, including over 30 million adults in the United States. Knee osteoarthritis occurs more frequently in postmenopausal women than in males.

Osteoarthritis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Osteoarthritis Treatment Market

Over the projected period, the osteoarthritis treatment market was expected to be constrained by the COVID-19 outbreak. Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This virus spread quickly over the world, killing many people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in many nations had imposed nationwide lockdowns to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world were having difficulty continuing their supply chain activities. The osteoarthritis treatment market was hampered by the supply chain slowness.

Recent Development

• In December 2020, Moebius Medical had announced the US Food and Drug Administration (FDA) clearance for its investigational new drug (IND) application for initiating a global multi-center Phase IIb clinical trial of MM-II, which is a novel candidate for the treatment of pain due to knee osteoarthritis (OA).

Global Osteoarthritis Treatment Market Scope

The osteoarthritis treatment market is segmented on the basis of anatomy, drug type, treatment type, diagnosis, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Anatomy

• Hand Osteoarthritis
• Knee Osteoarthritis
• Hip Osteoarthritis
• Small Joint Osteoarthritis

Drug Type

• Prescription Drugs
• Over-the-Counter Drugs

Treatment Type

• Medication
• Duloxetine
• Acetaminophen
• Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
• Corticosteroids
• Others
• Surgery
• Joint Replacement
• Realigning Bones
• Lubrication Injections
• Cortisone Injections
• Therapy
• Transcutaneous Electrical Nerve Stimulation (TENS)
• Occupational Therapy
• Physical Therapy

Diagnosis

• Imaging Tests
• Magnetic resonance imaging (MRI)
• X-rays
• Joint Fluid Analysis
• Blood Tests
• Others

Dosage form

• Tablets
• Injections
• Others

Route of Administration

• Oral
• Parenteral
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Osteoarthritis Treatment Market Regional Analysis/Insights

The osteoarthritis treatment market is analysed and market size insights and trends are provided by country, anatomy, drug type, treatment type, diagnosis, dosage form, route of administration, end-users and distribution channel as referenced above.

The countries covered in the osteoarthritis treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the osteoarthritis treatment market because of the launch of new treatment options in this region. Additionally, rising healthcare expenditure along with the availability of treatment options will further propel the 'market's growth rate in this region.

Asia-Pacific is expected to grow during the forecast period due to presence of generic manufacturers in this region. Also, development of healthcare infrastructure and rising geriatric population will further propel the 'market's growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Osteoarthritis Treatment Market Share Analysis

The Osteoarthritis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to osteoarthritis treatment market.

Some of the major players operating in the osteoarthritis treatment market are:

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (U.S.)
• Teva Pharmaceutical Industries Ltd.(Israel)
• Sanofi (France), Pfizer Inc. (U.S.)
• GlaxoSmithKline plc (U.K.)
• Novartis AG (Switzerland)
• Zydus Cadila (India)
• Boehringer Ingelheim International GmbH. (Germany)
• Apotex Inc. (Canada)
• AstraZeneca (U.K.)
• Horizon Therapeutics PLC (Ireland)
• Johnson & Johnson Private Limited (U.S.)
• Bayer AG (Germany)
• Perrigo Company plc (Ireland)
• Tolmar Pharmaceuticals, Inc. (U.S.)
• Reckitt Benckiser Group PLC (U.K.)
• 太阳制药工业有限公司 (印度)
• Assertio Therapeutics, Inc.（美国）
• 第一三共株式会社（日本）

SKU-53320